S-3 SANALESCA
S-3 SANALESCA
Discontinued
DIN Number
00696501
Drug Class
Human
Market Date
Dec 31, 1986
Company
HC
biocentre
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00696501
AIG Number0618325001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification
ACTIVE INGREDIENTS (6)
ARSENIC TRIOXIDEActive
Strength: 60 X / X
Monograph: ARSENIC TRIOXIDE
CALCIUM IODIDEActive
Strength: 30 X / X
Monograph: CALCIUM IODIDE
LOBELIA INFLATAActive
Strength: 30 X / X
Monograph: LOBELIA INFLATA
MAGNESIUM PHOSPHATE DIBASICActive
Strength: 6 X / X
Monograph: MAGNESIUM PHOSPHATE DIBASIC
POTASSIUM PHOSPHATE DIBASICActive
Strength: 12 X / X
Monograph: POTASSIUM PHOSPHATE DIBASIC
SODIUM PHOSPHATE DIBASICActive
Strength: 12 X / X
Monograph: SODIUM PHOSPHATE DIBASIC